1. Home
  2. IVVD vs PHD Comparison

IVVD vs PHD Comparison

Compare IVVD & PHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVVD
  • PHD
  • Stock Information
  • Founded
  • IVVD 2020
  • PHD 2004
  • Country
  • IVVD United States
  • PHD United States
  • Employees
  • IVVD N/A
  • PHD N/A
  • Industry
  • IVVD Biotechnology: Pharmaceutical Preparations
  • PHD Investment Managers
  • Sector
  • IVVD Health Care
  • PHD Finance
  • Exchange
  • IVVD Nasdaq
  • PHD Nasdaq
  • Market Cap
  • IVVD 123.8M
  • PHD 121.9M
  • IPO Year
  • IVVD 2021
  • PHD N/A
  • Fundamental
  • Price
  • IVVD $1.01
  • PHD $9.54
  • Analyst Decision
  • IVVD Strong Buy
  • PHD
  • Analyst Count
  • IVVD 4
  • PHD 0
  • Target Price
  • IVVD $7.89
  • PHD N/A
  • AVG Volume (30 Days)
  • IVVD 8.5M
  • PHD 67.7K
  • Earning Date
  • IVVD 03-27-2025
  • PHD 01-01-0001
  • Dividend Yield
  • IVVD N/A
  • PHD 11.43%
  • EPS Growth
  • IVVD N/A
  • PHD N/A
  • EPS
  • IVVD N/A
  • PHD 1.27
  • Revenue
  • IVVD $11,564,000.00
  • PHD N/A
  • Revenue This Year
  • IVVD N/A
  • PHD N/A
  • Revenue Next Year
  • IVVD $599.08
  • PHD N/A
  • P/E Ratio
  • IVVD N/A
  • PHD $7.60
  • Revenue Growth
  • IVVD N/A
  • PHD N/A
  • 52 Week Low
  • IVVD $0.36
  • PHD $8.30
  • 52 Week High
  • IVVD $4.74
  • PHD $9.81
  • Technical
  • Relative Strength Index (RSI)
  • IVVD 46.50
  • PHD 30.54
  • Support Level
  • IVVD $0.85
  • PHD $9.51
  • Resistance Level
  • IVVD $1.27
  • PHD $9.57
  • Average True Range (ATR)
  • IVVD 0.23
  • PHD 0.05
  • MACD
  • IVVD -0.08
  • PHD -0.02
  • Stochastic Oscillator
  • IVVD 12.80
  • PHD 15.38

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

About PHD Pioneer Floating Rate Fund Inc.

Pioneer Floating Rate Trust is a diversified, closed-end fund. Its investment objective is to provide a high level of current income and seek the preservation of capital by investing predominantly in floating-rate loans.

Share on Social Networks: